| Year |
Citation |
Score |
| 2016 |
Cosgrove LJ, Surinya K, Fung KY, Priebe I, Buckley M, Adams T, Tabor B, Purins L, Lockett T, Leroux H, Gibbs P, Wei J, Nice E, Burgess T, Thomas M, et al. Abstract 4920: Evaluation of a diagnostic blood test for colorectal cancer screening and as a triage tool to stratify patients for colonoscopy Cancer Research. 76: 4920-4920. DOI: 10.1158/1538-7445.Am2016-4920 |
0.39 |
|
| 2016 |
Lannagan TR, Mano MT, Head RJ, Lockett T, Ernst M, Cosgrove LJ. Abstract 4058: DNA damage and tumour burden in mouse colon is increased in response to carcinogen exposure after induction of chronic inflammation - a more disease relevant model of colitis-associated colorectal cancer Cancer Research. 76: 4058-4058. DOI: 10.1158/1538-7445.Am2016-4058 |
0.338 |
|
| 2015 |
Pedersen SK, Baker RT, McEvoy A, Murray DH, Thomas M, Molloy PL, Mitchell S, Lockett T, Young GP, LaPointe LC. A two-gene blood test for methylated DNA sensitive for colorectal cancer. Plos One. 10: e0125041. PMID 25928810 DOI: 10.1371/journal.pone.0125041 |
0.326 |
|
| 2015 |
Fung KY, Tabor B, Buckley MJ, Priebe IK, Purins L, Pompeia C, Brierley GV, Lockett T, Gibbs P, Tie J, McMurrick P, Moore J, Ruszkiewicz A, Nice E, Adams TE, et al. Blood-based protein biomarker panel for the detection of colorectal cancer. Plos One. 10: e0120425. PMID 25793510 DOI: 10.1371/Journal.Pone.0120425 |
0.372 |
|
| 2015 |
Fung KY, Purins L, Priebe IK, Pompeia C, Brierley GV, Tabor B, Lockett T, Gibbs P, Tie J, McMurrick P, Moore J, Ruszkiewicz A, Burgess A, Nice E, Cosgrove LJ. Analysis of 32 Blood-Based Protein Biomarkers for their Potential to Diagnose Colorectal Cancer Journal of Molecular Biomarkers & Diagnosis. 2015: 0-0. DOI: 10.4172/2155-9929.S6-003 |
0.345 |
|
| 2014 |
Ouakrim DA, Boussioutas A, Lockett T, Hopper JL, Jenkins MA. Cost-effectiveness of family history-based colorectal cancer screening in Australia. Bmc Cancer. 14: 261. PMID 24735237 DOI: 10.1186/1471-2407-14-261 |
0.35 |
|
| 2014 |
Fung KY, Nice E, Priebe I, Belobrajdic D, Phatak A, Purins L, Tabor B, Pompeia C, Lockett T, Adams TE, Burgess A, Cosgrove L. Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelled. World Journal of Gastroenterology : Wjg. 20: 888-98. PMID 24574763 DOI: 10.3748/Wjg.V20.I4.888 |
0.371 |
|
| 2014 |
Cosgrove LJ, Fung K, Priebe I, Purins L, Tabor B, Buckley M, Pompeia C, Brierley G, Nice E, Adams T, Gibbs P, Tie J, Ruszkiewicz A, Moore J, Lockett T, et al. Abstract 4099: Doctor Cancer Research. 74: 4099-4099. DOI: 10.1158/1538-7445.Am2014-4099 |
0.391 |
|
| 2013 |
Bennett L, Abeywardena M, Burnard S, Forsyth S, Head R, King K, Patten G, Watkins P, Williams R, Zabaras D, Lockett T. Molecular size fractions of bay leaf (Laurus nobilis) exhibit differentiated regulation of colorectal cancer cell growth in vitro. Nutrition and Cancer. 65: 746-64. PMID 23859043 DOI: 10.1080/01635581.2013.796999 |
0.346 |
|
| 2013 |
Fung KY, Priebe I, Purins L, Tabor B, Brierley GV, Lockett T, Nice E, Gibbs P, Tie J, McMurrick P, Moore J, Ruszkiewicz A, Burgess A, Cosgrove LJ. Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancer. Cancer Biomarkers : Section a of Disease Markers. 13: 75-9. PMID 23838135 DOI: 10.3233/Cbm-130335 |
0.327 |
|
| 2013 |
Brierley GV, Priebe IK, Purins L, Fung KY, Tabor B, Lockett T, Nice E, Gibbs P, Tie J, McMurrick P, Moore J, Ruszkiewicz A, Burgess A, Cosgrove LJ. Serum concentrations of brain-derived neurotrophic factor (BDNF) are decreased in colorectal cancer patients. Cancer Biomarkers : Section a of Disease Markers. 13: 67-73. PMID 23838134 DOI: 10.3233/Cbm-130345 |
0.309 |
|
| 2013 |
Fung KY, Ooi CC, Zucker MH, Lockett T, Williams DB, Cosgrove LJ, Topping DL. Colorectal carcinogenesis: a cellular response to sustained risk environment. International Journal of Molecular Sciences. 14: 13525-41. PMID 23807509 DOI: 10.3390/ijms140713525 |
0.356 |
|
| 2013 |
Cronin P, Goodall S, Lockett T, O'Keefe CM, Norman R, Church J. Cost-effectiveness of an advance notification letter to increase colorectal cancer screening. International Journal of Technology Assessment in Health Care. 29: 261-8. PMID 23778152 DOI: 10.1017/S0266462313000226 |
0.323 |
|
| 2013 |
Ait Ouakrim D, Lockett T, Boussioutas A, Hopper JL, Jenkins MA. Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis. Familial Cancer. 12: 459-72. PMID 23700069 DOI: 10.1007/s10689-013-9658-3 |
0.344 |
|
| 2013 |
Ait Ouakrim D, Lockett T, Boussioutas A, Keogh L, Flander LB, Hopper JL, Jenkins MA. Screening participation predictors for people at familial risk of colorectal cancer: a systematic review. American Journal of Preventive Medicine. 44: 496-506. PMID 23597814 DOI: 10.1016/j.amepre.2013.01.022 |
0.345 |
|
| 2013 |
Ross J, Lockett L, Brookes D, Tabor B, Duesing K, Buckley M, Lockett T, Molloy P, Macrae F, Young G, Blanco I, Capella G, Hannan GN. An association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non-syndromic predisposition. European Journal of Human Genetics : Ejhg. 21: 1389-95. PMID 23531863 DOI: 10.1038/ejhg.2013.53 |
0.33 |
|
| 2013 |
Kerr CA, Hines BM, Shaw JM, Dunne R, Bragg LM, Clarke J, Lockett T, Head R. Genomic homeostasis is dysregulated in favour of apoptosis in the colonic epithelium of the azoxymethane treated rat. Bmc Physiology. 13: 2. PMID 23343511 DOI: 10.1186/1472-6793-13-2 |
0.301 |
|
| 2013 |
Cronin P, Goodall S, Lockett T, O'Keefe C, Norman R, Church J. Cost–Effectiveness Of A Mailed Advance Notification Letter To Increase Colorectal Cancer Screening Value in Health. 16. DOI: 10.1016/J.Jval.2013.03.770 |
0.364 |
|
| 2012 |
Ait Ouakrim D, Lockett T, Boussioutas A, Keogh L, Flander LB, Winship I, Giles GG, Hopper JL, Jenkins MA. Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer. Cancer Causes & Control : Ccc. 23: 1853-64. PMID 23011536 DOI: 10.1007/s10552-012-0067-y |
0.336 |
|
| 2012 |
Fung KY, Cosgrove L, Lockett T, Head R, Topping DL. A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. The British Journal of Nutrition. 108: 820-31. PMID 22676885 DOI: 10.1017/S0007114512001948 |
0.375 |
|
| 2012 |
Ait Ouakrim D, Boussioutas A, Lockett T, Winship I, Giles GG, Flander LB, Keogh L, Hopper JL, Jenkins MA. Screening practices of unaffected people at familial risk of colorectal cancer. Cancer Prevention Research (Philadelphia, Pa.). 5: 240-7. PMID 22030089 DOI: 10.1158/1940-6207.CAPR-11-0229 |
0.348 |
|
| 2012 |
Saunders IW, Ross J, Macrae F, Young GP, Blanco I, Brohede J, Brown G, Brookes D, Lockett T, Molloy PL, Moreno V, Capella G, Hannan GN. Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families. European Journal of Human Genetics : Ejhg. 20: 91-6. PMID 21829229 DOI: 10.1038/ejhg.2011.149 |
0.323 |
|
| 2012 |
Brierley GV, Fung KY, Purins L, Priebe IK, Tabor B, Lockett T, Nice E, Gibbs P, Tie J, McMurrick P, Moore J, Ruszkiewicz A, Burgess A, Cosgrove LJ. Circulating Levels of the Wnt Antagonist Dkk-3 as a Diagnostic Markerfor Colorectal Cancer Journal of Molecular Biomarkers & Diagnosis. 2013: 0-0. DOI: 10.4172/2155-9929.S8-008 |
0.335 |
|
| 2012 |
Ouakrim DA, Boussioutas A, Lockett T, Flander L, Keogh L, Winship I, Giles G, Hopper J, Jenkins M. P-0184 Screening Practices of Australian Men and Women Categorised As “At or Slightly Above Average Risk” of Colorectal Cancer Annals of Oncology. 23. DOI: 10.1016/S0923-7534(20)30108-3 |
0.333 |
|
| 2012 |
Pedersen SK, Molloy PL, Baker R, McEvoy A, Thomas ML, Murray DH, Dunne R, Lockett T, Mitchell SM, Ho T, Ross JP, Brown G, Duesing K, Saunders NF, Buckley M, et al. 135 Discovery and Validation of a Novel DNA Methylation Biomarker for Colorectal Cancer With Application to Blood Testing Gastroenterology. 142: S-33. DOI: 10.1016/S0016-5085(12)60130-9 |
0.379 |
|
| 2010 |
Fung KY, Purins L, Tabor B, Priebe I, Pompeia C, Nice E, Burgess AW, Gibbs P, Lockett T, Cosgrove L. Biomarker panel discovery for early detection of colorectal cancer in blood samples F1000research. 1. DOI: 10.7490/F1000Research.622.1 |
0.329 |
|
| 2010 |
Fung KY, Brierley G, Henderson S, Lewanowitsch T, Priebe I, Hoffmann P, McColl SR, Kerr C, Shaw J, Buckley M, Lockett T, Head R, Cosgrove L. Application of proteomics and gene expression to identify potential mechanisms of butyrate-induced apoptosis in HT29 and HCT116 colorectal cancer cells F1000research. 1. DOI: 10.7490/F1000Research.567.1 |
0.333 |
|
| 2010 |
Saunders IW, Macrae FA, Young GP, Blanco I, Ross JP, Brohede J, Brown G, Brookes D, Lockett T, Molloy PL, Moreno V, Hannan GN. S1986 Evidence for a New Susceptibility Region on Chromosome 9 From a Genome-Wide Linkage Study in Non-Syndromic Colorectal Cancer Families Gastroenterology. 138: S-295. DOI: 10.1016/S0016-5085(10)61357-1 |
0.323 |
|
| 2009 |
Kerr CA, Dunne R, Hines BM, Zucker M, Cosgrove L, Ruszkiewicz A, Lockett T, Head R. Measuring the combinatorial expression of solute transporters and metalloproteinases transcripts in colorectal cancer. Bmc Research Notes. 2: 164. PMID 19689820 DOI: 10.1186/1756-0500-2-164 |
0.339 |
|
| 2009 |
Fung KY, Lewanowitsch T, Henderson ST, Priebe I, Hoffmann P, McColl SR, Lockett T, Head R, Cosgrove LJ. Proteomic analysis of butyrate effects and loss of butyrate sensitivity in HT29 colorectal cancer cells. Journal of Proteome Research. 8: 1220-7. PMID 19195990 DOI: 10.1021/pr8009929 |
0.331 |
|
| 1989 |
Lockett TJ, Ashburner M. Temporal and spatial utilization of the alcohol dehydrogenase gene promoters during the development of Drosophila melanogaster. Developmental Biology. 134: 430-7. PMID 2501128 DOI: 10.1016/0012-1606(89)90115-2 |
0.429 |
|
| Show low-probability matches. |